Keywords: endo, net, sales, surge, usa-based, specialty, pharmaceutical
Endo net sales surge 49% in 2003
Article | 23 February 2004
USA-based specialty pharmaceutical company Endo Pharmaceuticals has reported a leap in net sales of 49% to $595.6 million for full-year 2003. Top-line drivers ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
